Court grants preliminary approval of settlement to resolve all outstanding shareholder derivative litigation involving align

Tempe, ariz.--(business wire)--align technology, inc. (“align”) (nasdaq: algn) a leading global medical device company that designs, manufactures, and sells the invisalign® system of clear aligners, itero™ intraoral scanners, and exocad™ cad/cam software for digital orthodontics and restorative dentistry, today announced that the u.s. district court for the northern district of california has granted preliminary approval of a settlement to resolve shareholder derivative litigation that has been.
ALGN Ratings Summary
ALGN Quant Ranking